Eulerpool Terminal
The edge that pays for itself.
Current BridgeBio Pharma forecasts and price targets in August 2026
Ø Analyst Price Targets
94.64 USD
+11.54 %
Median
91.80 USD
+8.19 %
Max
164.85 USD
Min
68.11 USD
Last Price
84.85 USD
Buy
27
Hold
1
Sell
0
The average target price for BridgeBio Pharma is 94.64 USD. (+11.54 % above the current price)
The median price target of BridgeBio Pharma is 91.80 USD.
Stock analysts from many renowned investment banks are closely examining the BridgeBio Pharma stock. They conclude their professional BridgeBio Pharma stock analyses with a clear recommendation for the BridgeBio Pharma stock. The forecasts and price targets of professional analysts can be a good indicator of how a stock will perform in the next quarter.
| Buy | Hold | Sell | Ø Analyst Price Targets | |
|---|---|---|---|---|
| 2026-02-01 | 27 | 1 | 0 | 94.64 USD |
| 2026-01-01 | 25 | 1 | 0 | 90.56 USD |
| 2025-12-01 | 23 | 2 | 0 | 85.79 USD |
| 2025-12-01 | 23 | 2 | 0 | 85.26 USD |
| 2025-11-01 | 23 | 2 | 0 | 82.90 USD |
| 2025-11-01 | 23 | 2 | 0 | 71.13 USD |
BridgeBio Pharma Stock Forecast 2026: Revenue & Earnings Estimates
Analysts expect the following revenue and earnings for BridgeBio Pharma in the coming fiscal years:
| Fiscal year | Revenue | Net Income | Earnings per share |
|---|---|---|---|
| 2026e | 961.00 M USD | -433.00 M USD | -2.20 USD |
| 2027e | 1.60 B USD | 98.00 M USD | 0.50 USD |
| 2028e | 2.46 B USD | 731.00 M USD | 3.71 USD |